FindTrial
Sign In

The effect of metformin on PSA level

The effect of metformin on PSA level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PNRC-14004461
Enrollment
Unknown
Registered
2014-04-02
Start date
2014-08-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic diseases

Interventions

3:Blood sample for PSA levels

Sponsors

Kafkas University Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 40-80 years old; Patients with Type 2 Diabetes Mellitus and taking oral metformin and other antidiabetic agents

Exclusion criteria

Exclusion criteria: Age<40 years old

Design outcomes

Primary

MeasureTime frame
Decreas in PSA level;—

Countries

Turkey

Contacts

Public ContactAslan Demir

Kafkas University Faculty of Medicine

draslandemir@yahoo.com+90 5324658225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026